Johnson & Johnson opens Center for Device Innovation at TMC

This article was originally published here

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) said today that its J&J Medical Device Companies business opened the doors on the Center for Device Innovation at the Texas Medical Center, which aims to support breakthrough medical device tech development.

The project, a joint between Johnson & Johnson Innovation and the Texas Medical Center, is a 26,000-square-foot- facility designed to host JJMDC R&D staff to work on internal projects and “strategically aligned external ventures of JJMDC,” according to a press release.

“CDI @ TMC represents unprecedented collaboration between the scientists, business leaders, academicians and investors required to bring revolutionary medical devices from concept to market. With all these resources in one zip code, medical devices may be developed, tested, moved to clinical trials and regulatory approval, then provided to the doctors and patients around the world who need them faster than ever before,” Johnson & Johnson group worldwide chair Sandi Peterson said in a prepared statement.

The new center, originally announced in October, includes a new medical device engineering studio at the TMC Innovation Institute, staffed by J&J R&D workers, aimed at rapid prototyping and “fast failure” for early-and mid-stage projects.

The accelerator will also offer “broad access” to the preclinical facilities of Baylor College of Medicine, Houston Methodist Research Institute, and THI for testing novel devices with any organ system or disease-based application, the company said.

“We are excited to build upon our collaboration with the Johnson & Johnson Family of Companies through the launch of the Center for Device Innovation at the Texas Medical Center. We have already experienced tremendous growth within our ecosystem, and we believe that the CDI @ TMC will serve as a cornerstone for medical device invention and commercialization, further advancing our leadership in life sciences,” Texas Medical Center CEO William McKeon said in a press release.

Last week, Johnson & Johnson subsidiary Ethicon said it broke ground on a new factory in China’s Jiangsu province

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply